Discordant rifampicin susceptibility results are associated with Xpert(®) MTB/RIF probe B and probe binding delay

Yazar: Berhanu, R. H., Schnippel, K., Kularatne, R., Firnhaber, C., Jacobson, K. R., Horsburgh, C. R., Lippincott, C.K.
Yayımlandı Int J Tuberc Lung Dis (2019)

Discordant rifampicin susceptibility results are associated with Xpert® MTB/RIF probe B and probe binding delay

Yazar: Berhanu, R. H., Schnippel, K., Kularatne, R., Firnhaber, C., Jacobson, K. R., Horsburgh, C. R., Lippincott, C.K.
Yayımlandı Int J Tuberc Lung Dis (2019)

Overcoming limitations of tuberculosis information systems: researcher and clinician perspectives

Yazar: van der Heijden, Y. F., Hughes, J., Dowdy, D. W., Streicher, E., Chihota, V., Jacobson, K. R., Warren, R., Theron, G.
Yayımlandı Public Health Action (2019)

The impact of alcohol use on tuberculosis treatment outcomes: a systematic review and meta-analysis

Yazar: Ragan, E. J., Kleinman, M. B., Sweigart, B., Gnatienko, N., Parry, C. D., Horsburgh, C. R., LaValley, M. P., Myers, B., Jacobson, K. R.
Yayımlandı Int J Tuberc Lung Dis (2020)

Rise in rifampicin-monoresistant tuberculosis in Western Cape, South Africa

Yazar: Mukinda, F. K., Theron, D., van der Spuy, G. D., Jacobson, K. R., Roscher, M., Streicher, E. M., Musekiwa, A., Coetzee, G. J., Victor, T. C., Marais, B. J., Nachega, J. B., Warren, R. M., Schaaf, H. S.
Baskı/Yayın Bilgisi 2012